INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Atherosclerosis & Heart Disease desk →

1,829 studies · page 57 of 77

2016 / Intervention trial

A low-PAMP diet reduced LDL-cholesterol, abdominal circumference, and leukocyte activation markers in healthy men.

In 11 habitual consumers of high PAMP foods, adherence to a low PAMP diet for 7 days significantly reduced LDL-cholesterol (-0.69 mM, P = 0.024) and abdominal circumference (-1.6 cm, P = 0.001). Conversely, these markers and leukocyte counts (+14%, P = 0.017) increased significantly after 4 days of consuming predominantly high PAMP foods. In a separate group of 13 healthy men, leukocyte counts and CD11b expression on granulocytes and monocytes were significantly reduced after a fresh onion meal (P < 0.05), but this effect was reversed by a high PAMP equivalent meal.

Herieka M, Faraj TA, Erridge C Nutr Metab Cardiovasc Dis, 2016. PMID 26803597

2016 / Randomized controlled laboratory trial (two 8-d protocols)

Short-term circadian misalignment increased 24-hour blood pressure and inflammatory markers in healthy adults.

Researchers evaluated the impact of short-term circadian misalignment (12-h inverted behavioral and environmental cycles for 3 days) using two 8-day laboratory protocols in healthy adults. Circadian misalignment increased 24-h systolic blood pressure (SBP) by 3.0 mmHg and diastolic blood pressure (DBP) by 1.5 mmHg, driven mostly by increases during sleep opportunities (SBP, +5.6 mmHg; DBP, +1.9 mmHg). It also decreased wake cardiac vagal modulation by 8-15%, decreased 24-h urinary epinephrine excretion by 7% without affecting norepinephrine, and increased 24-h serum interleukin-6, C-reactive protein, resistin, and tumor necrosis factor-α levels by 3-29%.

Morris CJ, Purvis TE, Hu K, et al. Proc Natl Acad Sci U S A, 2016. PMID 26858430

2016 / Randomized controlled trial

Black raspberry extract decreased radial augmentation index and increased circulating EPCs in patients with metabolic syndrome over 12 weeks.

Fifty-one patients with metabolic syndrome were randomized to receive 750 mg/day of black raspberry extract (n = 26) or placebo (n = 25) for 12 weeks. Radial augmentation indexes significantly decreased in the black raspberry group compared with placebo (-5% ± 10% vs. 3% ± 14%, P < .05), and CD34/CD133(+) cells were significantly higher (19 ± 109/μL vs. -28 ± 57/μL, P < .05). Additionally, the black raspberry group showed significantly greater decreases in IL-6 (-0.5 ± 1.4 pg/mL vs. -0.1 ± 1.1 pg/mL) and TNF-α (-5.4 ± 4.5 pg/mL vs. -0.8 ± 4.0 pg/mL), along with significant increases in adiponectin (2.9 ± 2.1 μg/mL vs. -0.2 ± 2.5 μg/mL).

Jeong HS, Kim S, Hong SJ, et al. J Med Food, 2016. PMID 26891216

2016 / Randomized crossover trial

Aged garlic extract did not improve endothelial function or insulin resistance in diabetes

A randomized crossover pilot trial evaluated 26 adults with type 2 diabetes who consumed 1,200 mg of aged garlic extract or placebo daily for 4 weeks. Supplementation had no significant effect on insulin resistance or metabolic measures. In addition, aged garlic extract did not significantly alter markers of endothelial function, oxidative stress, or vascular inflammation in this high-risk population.

Atkin M, Laight D, Cummings MH J Diabetes Complications, 2016. PMID 26954484

2016 / Double-blind placebo-controlled randomized trial

Roselle calyx powder significantly decreased systolic blood pressure and serum triglycerides in adults with metabolic syndrome.

Forty adults with metabolic syndrome were randomly assigned to receive either 500 mg of Hibiscus sabdariffa calyx powder or placebo once daily for 4 weeks. Compared to placebo, H. sabdariffa significantly reduced serum triglycerides (p=0.044) and systolic blood pressure (p=0.049). All other measured variables—including diastolic blood pressure, BMI, fasting plasma glucose, insulin, lipoproteins, hs-CRP, and malondialdehyde—were not significantly affected.

Asgary S, Soltani R, Zolghadr M, et al. J Complement Integr Med, 2016. PMID 26982618

2016 / Randomized controlled trial

A 5-year Mediterranean diet intervention did not prevent telomere shortening compared to a low-fat diet in high cardiovascular risk subjects.

In the PREDIMED-NAVARRA trial, 520 participants at high cardiovascular risk were randomized to a low-fat control diet, a Mediterranean diet with extra virgin olive oil (MeDiet-EVOO), or with nuts (MeDiet-nuts) for 5 years. Baseline MeDiet adherence was linked to longer basal telomeres in women (score >=10: 0.27 vs. score <=6: -0.46, P=0.003) but the opposite in men (P interaction = 0.036). After 5 years, allocation to MeDiet-nuts was associated with greater telomere shortening (-0.24, 95% CI: -0.38 to -0.01; P=0.003), while MeDiet-EVOO showed no significant difference compared to control (P=0.537).

García-Calzón S, Martínez-González MA, Razquin C, et al. Clin Nutr, 2016. PMID 27083496

2016 / Randomized controlled trial

Adding flaxseed to lifestyle advice reduced metabolic syndrome prevalence and insulin resistance

A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.

Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322

2016 / Randomized controlled trial

Chlorella attenuated serum cholesterol increases during a high-cholesterol challenge in healthy adults.

In a randomized, double-blind, placebo-controlled study, 34 adults consumed 510 mg of cholesterol daily alongside 5 g per day of Chlorella or placebo for 4 weeks. Chlorella supplementation led to significantly smaller increases in total cholesterol (3.5% versus 9.8%, P = 0.037) and LDL-C (1.7% versus 14.3%, P = 0.012) compared to placebo. HDL-C increased by 8.3% with Chlorella versus 3.8% with placebo.

Kim S, Kim J, Lim Y, et al. Nutr J, 2016. PMID 27177615

2016 / Randomized crossover trial

Cranberry polyphenol juice dose-dependently improved flow-mediated dilation in healthy men.

In a randomized crossover study with ten healthy men, intake of cranberry juice delivering 409 to 1910 mg total polyphenols led to dose-dependent improvements in flow-mediated dilation from 1 to 8 hours post-consumption. Peak vascular effects occurred at 4 hours with the juice containing 1238 mg total polyphenols. Circulating concentrations of 12 distinct polyphenol metabolites significantly correlated with the flow-mediated dilation increases.

Rodriguez-Mateos A, Feliciano RP, Boeres A, et al. Mol Nutr Food Res, 2016. PMID 27242317

2016 / Randomized double-blind placebo-controlled clinical trial

Melissa officinalis supplementation significantly reduced LDL and AST levels compared with placebo in patients with borderline hyperlipidemia.

Fifty-eight hyperlipidemic patients were randomly assigned to receive capsules containing 1000 mg of Melissa officinalis leaf powder or placebo capsules three times per day for two months. After supplementation, mean LDL significantly decreased in the M. officinalis group compared with the placebo group (P=0.02), and AST also showed a significant difference between groups (P=0.009). Levels of cholesterol, fasting blood glucose, HDL, triglycerides, creatinine, and ALT showed no significant differences between the two groups after two months (P>=0.05).

Jandaghi P, Noroozi M, Ardalani H, et al. Complement Ther Med, 2016. PMID 27261994

2016 / Randomised controlled cross-over trial

A high-fat meal with Cheddar cheese significantly lowered postprandial C-reactive protein iAUC compared with a vegan alternative.

A randomized controlled cross-over trial in 20 overweight or obese adults with metabolic abnormalities compared the postprandial effects of two isoenergetic high-fat meals: one with Cheddar cheese and one with a vegan alternative, separated by a 1- to 2-week washout. Postprandial TAG concentrations rose steadily following both meals (P < 0.05) through 6 hours. The incremental AUC (iAUC) for CRP was significantly lower (P < 0.05) following the cheese meal compared with the vegan alternative, though no treatment effect was observed for other inflammatory markers.

NANO counterpoint →

Demmer E, Van Loan MD, Rivera N, et al. J Nutr Sci, 2016. PMID 27313852

2016 / Randomized controlled trial

Adding extended-release niacin with laropiprant to statin therapy reduced quality-adjusted life years and increased hospital costs over 4 years.

In the HPS2-THRIVE trial, 25,673 participants aged 50 to 80 years with prior cardiovascular disease receiving statin therapy were randomized to 2 g extended-release niacin with 40 mg laropiprant daily or placebo for 4 years. Participants assigned to niacin-laropiprant experienced non-significantly lower survival (0.012 fewer years [SE 0.007]), significantly fewer quality-adjusted life years (0.023 [SE 0.007] fewer using UK EQ-5D; 0.020 [SE 0.006] fewer using US EQ-5D), and higher hospital costs (UK £101 [SE £37]; US $145 [SE $53]). Stroke, heart failure, musculoskeletal, gastrointestinal, and infection events were associated with substantial declines in quality of life and increased hospital costs.

Kent S, Haynes R, Hopewell JC, et al. Circ Cardiovasc Qual Outcomes, 2016. PMID 27407053

2016 / Double-blind, randomized, placebo-controlled trial

In sedentary adults, daily dark chocolate intake for 3 months increased maximum work, improved muscle markers, and raised HDL levels.

Twenty sedentary adults aged ~50 were randomized to consume 20 g of dark chocolate or placebo daily for 3 months, with 17 completing the study. In the dark chocolate group (n = 9), VO2 max showed a 17% increase (p = 0.056) and maximum work achieved increased significantly (p = 0.026), alongside higher HDL (p = 0.005) and decreased triglycerides (p = 0.07), with no changes in placebo (n = 8). Skeletal muscle showed significant increases in LKB1, AMPK, and PGC1α proteins and their active forms, citrate synthase activity, and reduced glutathione, as well as decreased protein carbonylation, without changes in mitochondrial density. The authors note larger clinical studies are warranted to confirm these observations.

Taub PR, Ramirez-Sanchez I, Patel M, et al. Food Funct, 2016. PMID 27491778

2016 / Randomized controlled trial

Flaxseed reduced central blood pressure in participants with high baseline blood pressure.

Among 62 patients with peripheral artery disease who had high blood pressure at baseline, dietary flaxseed lowered central systolic and diastolic blood pressures by an average of 10 and 6 mm Hg compared to placebo. Flaxseed did not significantly alter the augmentation index or other cardiac function indices. The reduction in central blood pressure was linked to decreases in specific plasma oxylipins, including 16-hydroxyeicosatetraenoic acid and thromboxane B2.

Caligiuri SP, Rodriguez-Leyva D, Aukema HM, et al. Hypertension, 2016. PMID 27528063

2016 / Randomized crossover trial

Acute açai smoothie consumption improved flow-mediated dilatation and reduced oxidative status in men.

In a randomized double-blind crossover trial of 23 overweight men given a high-fat breakfast challenge, an açai smoothie increased flow-mediated dilatation by 1.4% at 2 hours and 0.8% at 6 hours, versus 0.4% and -0.3% for control. The açai beverage also lowered postprandial total peroxide oxidative status. Blood pressure, heart rate, and glucose remained unchanged, whereas early insulin peaks and overall post-meal insulin exposure were higher following açai.

Alqurashi RM, Galante LA, Rowland IR, et al. Am J Clin Nutr, 2016. PMID 27680990

2016 / 8-week randomized, double-blind, placebo-controlled trial

Anthocyanin-rich black soybean testa extract improved abdominal fat measurements and lipid profiles in overweight or obese Korean adults.

Sixty-three overweight or obese Korean adults were randomized to receive either 2.5 g/d of anthocyanin-rich black soybean testa extract (BBT, n=32) or placebo (2.5 g/d starch, n=31) for 8 weeks. The BBT group experienced significant decreases in abdominal fat (waist circumference and hip circumference) as well as reductions in triacylglycerols, LDL cholesterol, and non-HDL cholesterol. Arteriosclerosis indicators (TC/HDLc and LDLc/HDLc) also significantly decreased in the BBT group but remained unchanged in the placebo group, with no differences observed between groups in energy-adjusted dietary intakes or physical activity.

Lee M, Sorn SR, Park Y, et al. J Med Food, 2016. PMID 27809637

2015 / Pooled analysis of randomized controlled trials

Six months of soy food or isoflavone intake did not elevate uric acid.

A pooled analysis evaluated two 6-month randomized trials involving 450 postmenopausal women with prehypertension or prediabetes. Compared with milk placebo, participants receiving combined soy foods had a smaller decline in serum uric acid, resulting in a net difference of 14.5 micromol/L (95% CI: 1.93-25.6, p = 0.023) or 4.9% (95% CI: 1.3-8.5%, p = 0.023). Soy foods did not raise absolute urate levels.

Liu ZM, Ho CS, Chen YM, et al. Eur J Nutr, 2015. PMID 24659208

2015 / Controlled trial

A modified portfolio diet reduced LDL cholesterol and improved endothelial function in diabetic patients after bypass surgery.

Thirty patients with type II diabetes 6 weeks post-bypass surgery received counseling on a Modified Portfolio Diet (MPD) including low fat, viscous fibers, soy protein, and almonds, while 7 patients with no diet therapy served as time controls. Consumption of the MPD led to a 19% relative reduction in LDL cholesterol (1.9 ± 0.8 vs 1.6 ± 0.6 mmol/L, p < 0.001) with no change in HDL cholesterol, and homocysteine levels dropped (10.1 ± 2.7 vs 7.9 ± 4 μmol/L, p = 0.006). Flow-mediated dilatation increased from 3.8 ± 3.8% to 6.5 ± 3.6% (p = 0.004) in treated patients while remaining constant in controls (p = 0.6), and endothelial progenitor cell numbers increased significantly (p < 0.02). Time controls showed no significant changes across these measures.

Keith M, Kuliszewski MA, Liao C, et al. Clin Nutr, 2015. PMID 25023926

2015 / Randomized controlled crossover trial

Substituting red meat with legumes in a TLC diet improved lipid profiles and glycemic control in participants with type 2 diabetes.

Thirty-one type 2 diabetes patients were randomized in a crossover trial to an 8-week legume-free Therapeutic Lifestyle Change (TLC) diet and an 8-week legume-based TLC diet (replacing two servings of red meat with legumes 3 days per week), separated by a 4-week washout. Compared with the control diet, the legume-based diet significantly decreased fasting blood glucose (P=0.04), fasting insulin (P=0.04), triglycerides (P=0.04), and LDL cholesterol (P=0.02). Total cholesterol decreased in both diets with no significant difference between them, and BMI, waist circumference, and systolic and diastolic blood pressure did not change significantly between diets.

Hosseinpour-Niazi S, Mirmiran P, Hedayati M, et al. Eur J Clin Nutr, 2015. PMID 25351652

2015 / Randomized controlled crossover trial

Antibacterial mouthwash use for 3 days reduced oral nitrate reduction and raised systolic blood pressure in treated hypertensive adults.

A randomized controlled crossover trial investigated the effects of 3-day antibacterial mouthwash use compared to control (water) in 15 treated hypertensive men and women. Mouthwash use led to decreased oral nitrate to nitrite reduction (P = 0.02), lower salivary nitrite (P = 0.01), higher salivary nitrate (P < 0.001), and a trend toward lower plasma nitrite (P = 0.09). In addition, mouthwash significantly increased systolic blood pressure relative to control (2.3 mm Hg; 95% CI: 0.5, 4.0; P = 0.01), with no significant effect on diastolic blood pressure (P = 0.4) or plasma cGMP (P = 0.7).

Bondonno CP, Liu AH, Croft KD, et al. Am J Hypertens, 2015. PMID 25359409

2015 / Parallel, single-blind randomized controlled trial

Brown and golden flaxseed intake reduced diastolic blood pressure in overweight adolescents but did not differentially affect lipids or glucose.

Seventy-five overweight adolescents were randomized to consume 28 g/day of brown flaxseed, golden flaxseed, or wheat bran (control) on weekdays for 11 weeks. Groups consuming brown and golden flaxseed demonstrated a significant reduction in diastolic blood pressure. Neither flaxseed variety differentially affected plasma lipids, glucose, or inflammatory profile, and all three groups showed increased TNF-α levels. The authors noted that adolescents consumed only about half the provided amount, which may have been insufficient to influence lipids, inflammation, or body composition.

Machado AM, de Paula H, Cardoso LD, et al. Nutrition, 2015. PMID 25441591

2015 / Randomized crossover controlled-feeding trial

Almond snacking lowered LDL cholesterol and central adiposity in adults with elevated cholesterol

In a randomized crossover controlled-feeding trial of 48 adults with high LDL cholesterol, consuming 1.5 oz daily of almonds for six weeks lowered non-HDL cholesterol by 6.9±2.4 mg/dL (P=0.01) and LDL cholesterol by 5.3±1.9 mg/dL (P=0.01) compared to an isocaloric muffin snack. Almond intake also decreased abdominal fat by 0.07±0.03 kg (P=0.02) and leg fat by 0.12±0.05 kg (P=0.02) without altering total weight. The control snack reduced HDL cholesterol, whereas almonds maintained baseline concentrations.

Berryman CE, West SG, Fleming JA, et al. J Am Heart Assoc, 2015. PMID 25559009

2015 / Randomized controlled trial

Daily blueberry powder reduced blood pressure and arterial stiffness in postmenopausal women.

In an eight-week trial, 48 postmenopausal women with pre- and stage 1-hypertension received 22 g daily of freeze-dried blueberry powder or control powder. Systolic blood pressure (131±17 mm Hg, P<0.05), diastolic blood pressure (75±9 mm Hg, P<0.01), and brachial-ankle pulse wave velocity (1,401±122 cm/second, P<0.01) decreased significantly from baseline in the blueberry group, along with increased nitric oxide levels (15.35±11.16 μmol/L, P<0.01). No changes occurred in the control powder group.

Johnson SA, Figueroa A, Navaei N, et al. J Acad Nutr Diet, 2015. PMID 25578927

2015 / Randomized controlled trial

Adding 100 grams of almonds daily to statin therapy reduced non-HDL cholesterol.

A randomized trial assigned 48 adults receiving ongoing statin therapy to add 100 grams of almonds daily or follow diet counseling alone for four weeks. Participants in the almond group showed a 4.9% reduction in non-HDL cholesterol compared with a 3.5% increase in the control group (p = 0.02). Non-significant reductions occurred for LDL cholesterol and triglycerides (p = 0.068 for both), while LDL particle distribution shifted from pattern A to B.

Ruisinger JF, Gibson CA, Backes JM, et al. J Clin Lipidol, 2015. PMID 25670361